These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18270841)

  • 1. GH/GHRH axis in HIV lipodystrophy.
    Stanley TL; Grinspoon SK
    Pituitary; 2009; 12(2):143-52. PubMed ID: 18270841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.
    Sivakumar T; Mechanic O; Fehmie DA; Paul B
    HIV Med; 2011 Sep; 12(8):453-62. PubMed ID: 21265979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
    Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
    Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
    JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents.
    Viganò A; Mora S; Brambilla P; Schneider L; Merlo M; Monti LD; Manzoni P
    AIDS; 2003 Jul; 17(10):1435-41. PubMed ID: 12824780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.
    Brigante G; Diazzi C; Ansaloni A; Zirilli L; Orlando G; Guaraldi G; Rochira V
    Eur J Endocrinol; 2014 May; 170(5):685-96. PubMed ID: 24536088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
    Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
    J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone deficiency and human immunodeficiency virus.
    Rochira V; Guaraldi G
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):91-111. PubMed ID: 28477736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.
    Jain S; Desai N; Bhangoo A
    Rev Endocr Metab Disord; 2013 Jun; 14(2):113-8. PubMed ID: 23657561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.
    Benedini S; Terruzzi I; Lazzarin A; Luzi L
    BioDrugs; 2008; 22(2):101-12. PubMed ID: 18345707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic effects of GHRH in patients with HIV lipodystrophy: a model of acquired visceral adiposity.
    Grinspoon S
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):355. PubMed ID: 16932313
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.
    Falutz J; Potvin D; Mamputu JC; Assaad H; Zoltowska M; Michaud SE; Berger D; Somero M; Moyle G; Brown S; Martorell C; Turner R; Grinspoon S
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):311-22. PubMed ID: 20101189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.
    Stanley TL; Grinspoon SK
    Growth Horm IGF Res; 2015 Apr; 25(2):59-65. PubMed ID: 25555516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
    Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
    JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
    Koutkia P; Eaton K; You SM; Breu J; Grinspoon S
    AIDS; 2006 Apr; 20(6):855-62. PubMed ID: 16549969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.
    Zirilli L; Orlando G; Carli F; Madeo B; Cocchi S; Diazzi C; Carani C; Guaraldi G; Rochira V
    Eur J Endocrinol; 2012 Mar; 166(3):415-24. PubMed ID: 22189998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy.
    Koutkia P; Canavan B; Breu J; Grinspoon S
    J Clin Endocrinol Metab; 2005 Jan; 90(1):32-8. PubMed ID: 15483073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.